Breathe Well Live Well
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Other: ICS withdrawal; Other: Usual care
Sponsors: Radboud University; Novartis; Boehringer Ingelheim
Recruiting – verified February 2016
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
|
Doubt cast on LABA withdrawal in combination asthma therapy
News-Medical.net By Caroline Price, Senior medwireNews Reporter. Researchers have urged doctors to be cautious over withdrawal of long-acting beta-2 agonist (LABA) therapy in patients with asthma controlled by this type of bronchodilator in combination with an inhaled … |
View full post on asthma – Google News
|
LABA Withdrawal Increases Asthma-Related Impairment
Journal of the American Academy of Physician Assistants (HealthDay News) – For patients with asthma controlled with a combination of an inhaled corticosteroid (ICS) and a long-acting ?2-agonist (LABA), withdrawal of the LABA once asthma is controlled correlates with increased asthma-associated impairment. |
View full post on asthma – Google News
|
CARDIN SAYS WITHDRAWAL OF PROPOSED SMOG STANDARDS WILL HARM MARYLANDERS COST JOBS
PoliticalNews.me (press release) The decision to withdraw the proposed ozone standard is bad for the health of the 140000 Maryland children who have asthma and is based on bad economics. More than half of the smog that leads to asthma attacks every summer comes from out of state. … |
View full post on asthma – Google News